At a Glance
| 1B-LSD | 1cP-AL-LAD | |
|---|---|---|
| Class | Psychedelic | Psychedelic |
| Common Dose (oral) | 75–150 µg | 100–225 µg |
| Total Duration | 4.1–8 hrs | 3.3–7 hrs |
| Routes | oral | oral |
| Effects | 79 documented | 72 documented |
Dosage
oral
| Level | 1B-LSD | 1cP-AL-LAD |
|---|---|---|
| Threshold | 15 µg | 20 µg |
| Light | 25–75 µg | 50–100 µg |
| Common | 75–150 µg | 100–225 µg |
| Strong | 150–300 µg | 225–350 µg |
| Heavy | 300 µg | 350 µg |
Duration
oral
1B-LSD
oral
Total: 8 hrs – 12 hrsPeak
Offset
Afterglow
Onset20 min – 1 hrs
Come Up45 min – 2 hrs
Peak3 hrs – 5 hrs
Offset
Effects
Safety
Interaction: 1B-LSD + 1cP-AL-LAD
No direct interaction data available between these substances. This does not mean the combination is safe.
1B-LSD — Dangerous Interactions
No dangerous interactions recorded.
1cP-AL-LAD — Dangerous Interactions
No dangerous interactions recorded.
Frequently Asked Questions
What is the difference between 1B-LSD and 1cP-AL-LAD?
1B-LSD is classified as a Psychedelic (Lysergamides) while 1cP-AL-LAD is classified as a Psychedelic (Lysergamides). They share 63 effects in common, with 16 effects unique to 1B-LSD and 9 unique to 1cP-AL-LAD.
Is it safe to combine 1B-LSD and 1cP-AL-LAD?
There is no direct interaction data available for combining 1B-LSD and 1cP-AL-LAD. This does not mean the combination is safe. Always exercise caution and research thoroughly.
Which is stronger, 1B-LSD or 1cP-AL-LAD?
At common doses via oral, 1B-LSD is typically dosed at 75–150 µg while 1cP-AL-LAD is dosed at 100–225 µg. However, "stronger" depends on context — potency, subjective intensity, and duration all factor in. These substances have different pharmacological profiles and comparing raw potency is not straightforward.